Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$18.99 -1.60 (-7.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Other (2016 - 2026)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) reported Receivables - Other of $75 million for Q2 2026.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Other (2016 - 2026) Analysis & Trends

At the end of FY2017, Viridian Therapeutics, Inc.\DE posted Receivables - Other of $1.1 million, up 266.7% from FY2016.

  • By year, Receivables - Other came in at $300,000 in FY2016.
  • The Q2 2026 figure ranks as the highest quarterly Receivables - Other in data going back to Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Viridian Therapeutics, Inc.\DE 2.33 Bn 2.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.00 Mn
Sep 30, 2025 70.00 Mn
Sep 30, 2021 479,000.00
Mar 31, 2018 955,000.00
Dec 31, 2017 1.10 Mn
Sep 30, 2017 1.44 Mn
Jun 30, 2017 467,200.00
Dec 31, 2016 300,000.00
API Access

Viridian Therapeutics, Inc.\DE Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=VRDN&period=max&api_key=YOUR_API_KEY